Degeneration of locus coeruleus (LC) neurons and dysregulation of noradrenergic 48 signaling are ubiquitous features of Parkinson's disease (PD). The LC is among the first 49 brain regions affected by α-synuclein (asyn) pathology, yet how asyn affects these 50 neurons remains unclear. LC-derived norepinephrine (NE) can stimulate neuroprotective 51 mechanisms and modulate immune cells, while dysregulation of NE neurotransmission 52 may exacerbate disease progression, particularly non-motor symptoms, and contribute 53 to the chronic neuroinflammation associated with PD pathology. Although transgenic mice 54 overexpressing asyn have previously been developed, transgene expression is usually 55 driven by pan-neuronal promoters and thus has not been selectively targeted to LC 56 neurons. Here we report a novel transgenic mouse expressing human wild-type asyn 57 under control of the noradrenergic-specific dopamine β-hydroxylase promoter. These 58 mice developed asyn aggregates in LC neurons, alterations in hippocampal and LC 59 microglial abundance, upregulated GFAP expression, degeneration of LC fibers, 60 decreased striatal dopamine metabolism, and age-dependent behaviors reminiscent of 61 non-motor symptoms of PD. These mice provide novel insights into how asyn pathology 62 affects LC neurons and how LC dysfunction may contribute to early PD pathophysiology. 63 Significance statement 64 ɑ-synuclein (asyn) pathology and loss of neurons in the locus coeruleus (LC) are two of 65 the most ubiquitous neuropathologic features of Parkinson's disease (PD). Dysregulated 66 NE neurotransmission is associated with the non-motor symptoms of PD including sleep 67 disturbance, emotional changes such as anxiety and depression, and cognitive decline.
expression has been used to target asyn overexpression to specific brain regions 114 which co-terminated with CS presentation. The contextual test was conducted on the 195 following day when animals were placed back into the same chamber. On day three, the 196 animals were placed in a novel compartment and allowed to habituate for 2 min. Following 197 habituation, the 85 db tone was presented, and the amount of freezing behavior recorded. Immunohistochemistry. Brain tissue was sectioned on a freezing microtome (Leica 209 SM2010R, Buffalo Grove, IL) at 40µm and stored in cryoprotectant (30% ethylene glycol, 210 30% sucrose, 13.32mM NaH2PO4, 38.74mM Na2HPO4, 250µM Polyvinylpyrrolidone) 211 solution at -20°C until staining. Sections were washed in PBS before blocking in 5% 212 normal goat serum (Jackson ImmunoResearch 005-000-121; NGS) with 0.05% Triton X-213 100 (Sigma #T9284100) in Tris-buffered saline pH 7.4 (TBS) for 1 h at room temperature. 214
Sections were transferred directly to primary antibody solution containing 1% NGS, 0.05% 215
Triton-X 100, and antibody at the concentrations described in Table 1 and incubated 216 overnight at room temperature (05-02 Ms anti-NET, 1:1,000) or 4°C (all other primary 217 antibodies). Fluorescently conjugated secondary antibodies (described in Table 1) were 218 diluted in 0.1% NGS with 0.05% Triton X-100, and tissue sections were incubated for 1 h 219 at room temperature in the dark. Sections were mounted on Superfrost Plus slides (VWR) 220 and were coverslipped with Vectashield with DAPI (Vector). All immunofluorescent 221 images were acquired as z-stack images and the file compressed on a Keyence BZ-X700 222 microscope system (Itasca, IL). The Allen Brain Atlas version 1 (2008) was used to 223 identify regions of interest (ROIs). One section per mouse containing the dorsal 224 hippocampus (near bregma -1.995 mm) and one containing the LC (bregma -5.555 mm) 225
were analyzed for percent immunoreactivity (IR) within a standard ROI. A detection 226 threshold was set uniformly across images in each analysis, and % IR determined using 227 the "Measure" feature of ImageJ. Percent IR was calculated as area of IR within the ROI 228 divided by the total ROI area and multiplied by 100. Quantification of Iba1-positive cells (microglia) was also analyzed with a standard threshold, ROI, and upper and lower size 230 limits (pixel^2) using the "Analyze particles" function in ImageJ. 231
Proximity ligation assay (PLA). Paraffin embedded tissue was rehydrated by 232 consecutive incubations in Xylene, Histoclear, 100% ethanol, 95% ethanol, 70% ethanol 233 and H2O. Samples were then incubated in 10% H2O2 in PBS to reduce background and 234 heated in a microwave in citrate buffer (pH 6.0; Abcam) for antigen retrieval. After antigen 235 retrieval, samples were processed for immunofluorescence: 1 h RT incubation in 10% 236
Serum with 0.05% Tween-20 in TBS block, 1 h incubation in primary antibody, TBS with 237 0.05% Tween-20 (TBS-T) wash. Slides were then incubated for 1 h with secondary 238 antibodies (Alexa488 Life Technologies), and washed again with TBS-T. For 239 immunohistochemistry, samples were then coverslipped with FluorSave (Calbiochem). 240
For PLA, samples were covered in manufacturers PLA blocking solution (Sigma) for 1 h 241 at 37°C, and then incubated overnight with PLA conjugates (a-syn211; ab80627 Abcam). 242
On the next day, samples were washed with TBS-T, incubated in ligation solution for 1 h 243 at 37C°, washed with TBS-T, incubated in amplification solution for 2.5 h at 37C°, washed 244 with TBS, counterstained with DAPI, and mounted with FluorSave. All PLA reagents were 245 used as per manufacturer's instructions (Sigma; cat #92008). 246 PLA puncta were counted blindly from 25 cells per LC section per animal. Two 247 independent experimental rounds were normalized and averaged in order to provide the 248 final quantification. 249 250 RNA Scope. In situ RNA analysis was performed using RNAScope Multiplex Fluorescent 251 v2 kit (ACD Bio 3231000). Tissue prep and analysis were conducted as described in 252 manufacturer's protocol. Briefly, following transcardial perfusion with saline, brains were 253 incubated in 4% paraformaldehyde (PFA) for 24 hours followed by a series of increasing 254 sucrose concentrations before being frozen in optimal temperature cutting medium 255 (Sakura) and stored at -80°C until sectioning. Tissue sections (12µm) were collected on 256 
High performance liquid chromatography (HPLC).
Monoamines were examined by high performance liquid chromatography with 280 electrochemical detection as described previously (Song et al., 2012) . For HPLC, an ESA 281 5600A CoulArray detection system, equipped with an ESA Model 584 pump and an ESA 282 542 refrigerated autosampler was used. Separations were performed using an MD-150 × 
Human asyn is expressed in LC neurons of DBH-hSNCA transgenic mice 314
Human asyn protein was analyzed by immunofluorescence and western blot. Using an 315 antibody specific for human asyn (Biolegend 807801), expression of human asyn was 316 found to co-localize with TH-expressing LC neurons only in brain sections from DBH-317
hSNCA Tg mice (Fig. 3A) . No human asyn-specific immunofluorescence was detected 318 in LC neurons of nTg littermates or in SNpc neurons regardless of genotype (Fig. 3A,C) . 319
Human asyn was also detectable specifically in LC protein lysate from Tg tissue by 320 immunoblot and not in nTg lysates (Fig 3B; n=4) . Quantitative western blot analysis of LC 321 protein using a pan-asyn antibody to detect both human and mouse asyn protein revealed 322 a significant ~30% increase of total asyn in Tg mice at 3-mo relative to that in nTg 323 littermates ( Fig 3D; t(6 
DBH-hSNCA mice exhibit behavioral phenotypes that resemble features of non-326 motor PD symptoms 327
A primary role of the LC-NE system is promoting arousal and wakefulness; LC activity is 328 highest just prior to, and during wake (Hobson et al., 1975) . p=0.0286), with no differences in freezing behavior during the cued test ( Fig 4F) . No 355 genotype differences were found in the fear training ( Fig 4D) , contextual test ( Fig 4E) , or 356 cued test ( Fig 4F) in 3-or 24-mo old mice. 357
Because disruption in locomotor activity can affect behavioral testing, we evaluated the 358 locomotion over 24 h and found no genotype differences at 3-(F(1, 12)=1.158, p=0.3031; 359 n=7), 14-(F(1, 11)=0.1864, p=0.6743; n=7), or 24-mos (F(1, 13)=0.0603, p=0.8099; n=7-8) of 360 age (Fig. 4F) . Initially, all groups had high levels of activity, as would be expected in a 361 novel environment, which decreased as mice habituated to the test apparatus. 362
Ambulations increased normally in all genotypes at commencement of the dark phase, 363 when mice are typically more active, and decreased once the next light cycle began. 364
However, the 14-mo old Tg mice exhibited significantly more rearing behavior during the 365 dark phase than the nTg mice ( Fig 4G; Interaction F(21, 231)=1.911, p=0.0113). 366 367
Human asyn forms aggregates in LC neurons at 14-mos of age 368
To determine whether transgenic expression of human asyn in LC neurons leads to 369 formation of asyn aggregates, tissue sections containing the LC were analyzed using a 370 human asyn proximity ligation assay (PLA). In 14-mo old Tg mice (Fig 5) , LC neurons 371 displayed more asyn puncta per field than LC neurons from nTg mice (t(8)=2.532, 372 p=0.0352; n=4-6). Asyn aggregates are fibril-rich and highly phosphorylated at residue 373 129 (pSer129), and labeling these forms of the protein is commonly used to identify asyn 374 aggregates (Fujiwara et al., 2002; Wakamatsu et al., 2007; Schell et al., 2009) . Therefore, 375
we immunolabeled tissue sections with an antibody specific for fibril-rich asyn (Syn-F1) 376 or asyn pSer129 and found no detectable signal (data not shown), suggesting that at 14 377 mos of age the asyn-immunoreactive puncta are likely to represent intermediate asyn 378
oligomers rather than mature aggregates. 379 380
Human asyn expression in LC neurons impacts striatal dopamine metabolism in 381

24-mo old mice 382
Dysregulated catecholamine metabolism and degeneration of catecholaminergic neurons 383 are well-established features of PD (Iversen et al., 1983; Mann et al., 1983; Hirsch et al., 384 1988; Fearnley and Lees, 1991) . Therefore, we measured catecholamine levels using 385 high-performance liquid chromatography (HPLC). Hippocampal and striatal tissue 386 content of NE, the NE metabolite MHPG, DA, and the DA metabolite DOPAC were 387 quantified, revealing that NE (Fig. 6A,B) and DA (Fig. 6E,F) were not significantly affected 388 in the hippocampus or striatum at any age Similarly, the ratio of the major NE metabolite 389 MHPG to NE was unaffected (Fig, 6C,D) . The ratio of the DA metabolite DOPAC to DA 390 in the hippocampus was unaltered (Fig. 6G) , but was significantly reduced in the Tg 391 striatum at 24-mos ( Fig 6H; t(10 
Human asyn expression does not affect LC neuronal integrity 395
LC neurons were visualized using NET immunoreactivity (IR). NET is a reliable marker of 396 LC neurons, and its expression is reduced in PD patients (Remy et al., 2005) . Using a 397 standard ROI, no difference in the percent NET IR was detected between genotypes at 398 3- (Fig 7; t(17)=0.4537, p=0.6558; n=9-10), 14-(t(10)=0.8908, p=0.3939; n=5-7), or 24-mos 399 (t(8)=0.8069, p=0.4430; n=5-7). 400
Elevation of tyrosine hydroxylase in the LC of DBH-hSNCA mice 401
Tyrosine hydroxylase (TH) is the rate-limiting enzyme in NE and DA synthesis, and its 402 long-term activity depends on its expression levels (Levitt et al., 1965; Haycock, 1993; 403 Kumer and Vrana, 1996) . To determine whether TH expression in the LC is affected by 404 human asyn, we assessed TH IR in sections from 3-, 14-, and 24-mo old mice. TH IR was 405 normalized to NET IR to control for potential differences in Bregma level between 406 sections. TH expression was increased in Tg LC neurons (Fig 8A,B) at both 3-407 (t(17)=2.154, p=0.0459; n=9) and 14-mo (t(10)=2.463, p=0.0335; n=5-7) of age. Western 408 blot analysis from 3-mo old TH-EGFP-expressing LC neurons (Fig 8C,D) confirmed 409 higher TH expression in Tg animals (t(10)=3.837, p=0.0033; n= 5-7). 410
Human asyn expression in LC neurons affects expression of local inflammatory 411 markers 412
A wealth of studies suggest that dysregulated noradrenergic neurotransmission is of myeloid cells in the brain (both brain-resident microglia and potentially infiltrating 418 monocytes), we quantified the number of Iba1-positive cells in the LC by 419 immunofluorescence. At 14-mo, there was a significant decrease in the number of Iba1-420 expressing cells in the LC of Tg animals (Fig 9A,B ; t(13)=2.845, p=0.0138; n=8), with no 421 changes at other ages. To determine astrocyte activation, we quantified glial fibrillary 422 acidic protein (GFAP) IR, commonly used as a protein marker of astrogliosis (Eng and 423 Ghirnikar, 1994) , in the LC. At 24-mo, there was a significant increase in astrocytic GFAP 424 expression in the LC of Tg animals (Fig 9C, D; t(10)=2.744, p=0.0207; n=5-7). 425
Human asyn expression in LC neurons is associated with loss of hippocampal LC 426 fibers at 24-mos 427
The LC is the sole source of hippocampal NE, which is necessary for proper memory 428 formation and retrieval (Devauges and Sara, 1991) . Noradrenergic LC fibers express 429 NET, and PD brain tissue shows substantial LC denervation (Pavese et al., 2011) . To 430 determine whether hippocampal LC projections degenerate in DBH-hSNCA mice, we 431 examined NET IR in the CA1, CA3, and dentate gyrus regions of the hippocampus. At 432 24-mos, we found a reduction in LC fibers in the dentate gyrus (Fig 12C,D; t(10)=2.974, 433 p=0.0156; n=5-7), with a trend for reduction in CA1 (Fig 12A, B ; t(10)=1.899, p=0.0901) 434 and CA3 (Fig 12E,F ; t(10)=1.538, p=0.1585). No differences were observed in mice at 3-, 435 or 14-mos. 436
Hippocampal astrogliosis and changes in number of hippocampal Iba1-expressing 438 cells in aged DBH-hSNCA mice 439
To determine whether degeneration of hippocampal LC projections is associated with 440 inflammation, GFAP IR was visualized in the CA1, CA3, and dentate gyrus regions of the 441 hippocampus. At 14-mos, there was a significant increase in GFAP expression in CA1 442 ( Fig 10A,B; t(19) =2.723 ,p=0.0135, n=9-12) and CA3 (Fig 10E,F; t(19) =2.275 ,p=0.0347), 443 but not the dentate gyrus (Fig 11C,D; t(19 we observed in the LC, the number of Iba1-expressing cells in CA1 was reduced in Tg 445 mice at 14-mos ( Fig 11; t(16 were reduced in the hippocampus of 24-mo old mice. This finding resembles the pattern 463 of neuron death observed in PD, with axon terminals degenerating prior to frank cell loss 464 in the LC (Hornykiewicz, 1998) . Interestingly, the selective loss of LC fibers in the dentate 465 gyrus of DBH-hSNCA mice is reminiscent of what we observed in TgF344-AD rat model 466 of Alzheimer's disease that accumulates tau pathology in the LC (Rorabaugh et al., 2017) . 467
To determine the functional outcome of asyn aggregates in LC neurons, we measured 468 catecholamine levels in the hippocampus and striatum. Despite the loss of hippocampal 469 LC fibers at 24-mos we did not detect changes in hippocampal NE content by HPLC, 470
which may indicate a compensatory enhancement in NE neurotransmission. We 471 observed a trend toward decreased striatal NE 24-mos, although it was not statistically 472 significant. The sparse innervation by NE, it is possible that changes in NE 473 neurotransmission are detectable in the striatum prior to more densely innervated 474 regions. Dysregulated DA metabolism is a central feature of PD (Leenders et al., 1990) , 475 and midbrain dopaminergic innervation to the striatum is modulated by LC-NE (Lategan 476 et al., 1990; Grenhoff et al., 1993; Rommelfanger and 477 Weinshenker, 2007) . Studies of catecholamine function in rodents show that enhancing 478 LC-NE stimulates midbrain DA release in the striatum, whereas LC lesions or NE 479 deficiency reduce striatal DA release (Lategan et al., 1990; Grenhoff et al., 1993; Schank 480 et al., 2006) . We found that at 24-mos, Tg mice had a reduced striatal ratio of DOPAC:DA, 481 and a trend toward increased DA, suggesting that human asyn expression in aging LC 482 neurons causes a reduction in striatal DA turnover. Future studies will determine whether 483 NE innervation to midbrain DA neurons is reduced in 24-mo DBH-hSNCA mice, and 484 whether loss of noradrenergic transmission impairs striatal DA release. While no 485 significant differences were detected in hippocampal or striatal NE content at any age, Tg 486 LC neurons had increased TH expression at 3-and 14-mos relative to nTg littermates, 487
suggesting an increased capacity for NE synthesis. Sleep disturbances are one of the most common complaints of PD patients, and patients 522 who experience disturbed sleep appear to have greater LC asyn pathology than those 523 who do not report sleep disturbances (Kalaitzakis et al., 2013) . Anxiety is also a common 524 complaint, as up to 60% of PD patients report experiencing anxiety (Chaudhuri and 525 Schapira, 2009; Lin et al., 2015) . Importantly, DBH-hSNCA mice did not display changes 526 in the number or speed of ambulations relative to nTg mice at any age examined, ruling 527 out a general locomotor abnormality that has been observed in more ubiquitous asyn 528 overexpression mice (Giasson et al., 2002; Fleming et al., 2004; Graham and Sidhu, 529 2010) . 530
We have previously speculated that asyn pathology promotes LC hyperactivity and non-531 motor symptoms during PD progression prior to the degeneration of noradrenergic 532 neurons later in the disease (Weinshenker, 2018) , and the present data support that idea. 533
Indeed, the behavioral phenotypes we observed were most prominent at 14-mos, while 534 degeneration of LC fibers was not evident until 24-mos, a time when behavioral 535 abnormalities abated. There are several potential mechanisms by which increases in 536 asyn may be affecting the LC-NE system (Fig 13) . TH protein was increased in 3-and 537 14-mo old Tg mice, which is when behavioral phenotypes consistent with NE over-activity 538 emerged. Because TH is the rate-limiting enzyme in NE production, this may reflect 539 increased NE synthetic capacity, although the relevance is not clear because we did not 540 detect differences in tissue NE content. Human wild-type asyn has been reported to 541 increase in the size, and delay in the closing, of the vesicular fusion pore, allowing more 542 neurotransmitter to spill into the extracellular space (Larsen et al., 2006; Logan et al., 543 2017 ). In addition, viral-mediated overexpression of A53T mutant asyn in LC neurons 544 causes increased firing rate (Henrich et al., 2018) . Alternatively, if human asyn expression 545 is negatively impacting LC neuron health as suggested by the presence of asyn 546 aggregates at 14-mos and the loss of hippocampal LC fibers at 24-mos, there may be 547 compensatory increases in neuronal activity. Chemical lesion of LC neurons transiently 548 increases NE neurotransmission by increasing neuronal firing frequency and activity 549 patterns (Szot et al., 2016) . Future studies directly examining LC neuron firing and NE 550 release will be necessary to identify the mechanism in play here. 551
Little is known about the potential involvement of other brainstem NE regions in PD. One 552 study reported increased DBH activity in the A2/C2 of PD patients versus healthy controls 553 (Molinoff and Axelrod, 1971; Kopp et al., 1982) . While generally considered an integrative 554 region for autonomic functions, A2/C2 neurons are activated by stress and can influence 555 behavior (Cecchi et al., 2002; Ritter et al., 2003) . Future studies are required to determine 556 if other central noradrenergic regions contribute to the DBH-hSNCA phenotype. 557 LC neurons are among the first affected in PD, and the features of DBH-hSNCA mice 558 may represent early pathology and non-motor components of PD that provide insight into 559 the functional impact of human asyn expression in LC neurons during aging. Additionally, 560 studies involving exposure to environmental factors that synergize with asyn expression 561 to influence the risk of PD will likely elucidate the genetic and environmental interactions 562 that contribute to LC involvement in the pre-clinical pre-motor stages of PD, as well as 563 the impact of LC degeneration on the trajectory of PD pathogenesis. 564
